This is illustrated by a case study on treatment choices of breast cancer patients following genotyping for CYP2D6, recently published in Genome Medicine.
In our multiple case study two treatment conditions will be compared: one functions as the experimental condition in which the Collaborative Care Program is provided; the other condition functions as the control condition in which Care as Usual (CAU) is offered.
Randomized controlled trials utilizing "hard" clinical endpoints are advocated as the most efficient and reliable way to directly assess the benefits and harms of a therapy; however, using a case study of treatments for hepatocellular carcinoma, we highlight the challenges that can complicate even the highest levels of evidence.
It is a Middle English translation of an earlier Latin treatise on disease, containing case studies and treatment recipes.
Further clinical studies, including case studies and treatment experience, are necessary to confirm this point of view.
During these sessions, case studies and treatment guidelines were discussed.
There were also two case studies evaluating treatment mechanisms of counseling in Burundi and South Sudan for children in need of individual-level care; however, counseling was provided by a non-specialist (hence included in the focused care level) [ 20, 21].
After the first selection round, 35 studies were rejected for the following reasons: 27 studies did not evaluate treatment effects, 2 studies did not present data on the effectiveness of treatment (narrative case study), 5 studies evaluated treatment in adult subjects, and 1 study was not available in English or could be translated.
In both case studies, control treatments were included where the treatment solutions were replaced with sterile distilled water.
Reference Library, Process Builder, Case Study Manager, and Treatment Adviser.
